Beck Mack & Oliver LLC grew its holdings in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 22.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 201,248 shares of the company's stock after purchasing an additional 37,348 shares during the period. Beck Mack & Oliver LLC's holdings in Nutrien were worth $9,006,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also modified their holdings of NTR. Norges Bank acquired a new position in Nutrien during the 4th quarter valued at about $241,958,000. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Nutrien by 159.5% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 5,435,627 shares of the company's stock valued at $242,976,000 after acquiring an additional 3,341,169 shares in the last quarter. ARGA Investment Management LP increased its stake in shares of Nutrien by 25.7% during the fourth quarter. ARGA Investment Management LP now owns 6,043,590 shares of the company's stock valued at $270,396,000 after acquiring an additional 1,236,671 shares during the period. Silchester International Investors LLP raised its holdings in Nutrien by 9.5% during the fourth quarter. Silchester International Investors LLP now owns 11,693,137 shares of the company's stock worth $523,268,000 after purchasing an additional 1,009,895 shares in the last quarter. Finally, Barclays PLC lifted its position in Nutrien by 192.7% in the fourth quarter. Barclays PLC now owns 411,056 shares of the company's stock worth $18,395,000 after purchasing an additional 854,543 shares during the period. 63.10% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. The Goldman Sachs Group began coverage on Nutrien in a research report on Thursday, March 13th. They set a "sell" rating and a $53.00 price target on the stock. Piper Sandler boosted their price target on shares of Nutrien from $58.00 to $63.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. JPMorgan Chase & Co. upgraded shares of Nutrien from an "underweight" rating to a "neutral" rating and raised their price objective for the company from $40.00 to $50.00 in a research report on Monday, January 13th. Wells Fargo & Company boosted their target price on shares of Nutrien from $53.00 to $56.00 and gave the stock an "equal weight" rating in a report on Friday, February 21st. Finally, Barclays raised their target price on shares of Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a report on Wednesday, March 5th. Two analysts have rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $59.27.
Read Our Latest Stock Report on NTR
Nutrien Stock Up 1.5 %
Shares of NTR stock traded up $0.78 during trading on Thursday, hitting $53.86. 1,835,071 shares of the company were exchanged, compared to its average volume of 2,086,638. The business's 50-day simple moving average is $51.02 and its 200 day simple moving average is $49.33. Nutrien Ltd. has a twelve month low of $43.70 and a twelve month high of $60.87. The firm has a market capitalization of $26.33 billion, a price-to-earnings ratio of 39.30, a P/E/G ratio of 1.19 and a beta of 0.77. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.
Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $5.09 billion. As a group, analysts forecast that Nutrien Ltd. will post 3.72 EPS for the current fiscal year.
Nutrien Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Thursday, April 10th. Investors of record on Monday, March 31st were paid a $0.545 dividend. The ex-dividend date was Monday, March 31st. This represents a $2.18 annualized dividend and a dividend yield of 4.05%. Nutrien's payout ratio is 159.12%.
Nutrien Profile
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories

Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.